日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial

PCSK9抑制剂治疗影响microRNA表达和动脉壁特性变化:一项随机对照试验

Rehberger Likozar, Andreja; Levstek, Tina; Karun, Tina; Trebušak Podkrajšek, Katarina; Zupan, Janja; Šebeštjen, Miran

Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.

接受 PCSK9 抑制剂治疗的极高脂蛋白(a)患者的微小RNA、血清前蛋白转化酶枯草杆菌蛋白酶/Kexin 9 型 (PCSK9) 和脂质参数之间的相互作用

Levstek Tina, Karun Tina, Rehberger Likozar Andreja, Šebeštjen Miran, Trebušak Podkrajšek Katarina